Management of Urothelial Carcinoma / edited by Ja Hyeon Ku
Colaborador(es): SpringerLink (Online service)
.
Tipo de material:
E-bookSeries (Medicine (Springer-11650)).Editor: Singapore : Springer Singapore : Imprint: Springer, 2019Descripción: 1 recurso en línea (VI, 196 páginas 84 ilustraciones, 82 ilustraciones a color).ISBN: 9789811055027.Tema: Vejiga -- Cáncer
| Tipo de ítem | Biblioteca actual | Colección | Signatura topográfica | Estado | Fecha de vencimiento | Código de barras | Reserva de ítems | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Valencia Digital Acceso Electrónico (UEV) | Ciencias de la Salud | RC280 .M35 2019 EB (Navegar estantería(Abre debajo)) | Acceso electrónico |
I. Urothelial carcinoma of the bladder -- 1. Diagnosis -- 2. Treatment of non-muscle invasive bladder cancer -- 3. Treatment of muscle invasive bladder cancer -- 4. Treatment of advanced or metastatic bladder cancer -- II. Upper tract urothelial carcinoma -- 1. Diagnosis -- 2. Nephron-sparing surgery -- 3. Nephroureterectomy -- 4. Treatment of advanced or metastatic UTUC.
This book provides a comprehensive overview of contemporary evidence-based management of urothelial carcinoma. The first part of the book is devoted to urothelial carcinoma of the bladder and includes detailed description of the diagnosis and treatment of non-muscle-invasive, muscle-invasive, and advanced or metastatic disease. Attention then turns to upper tract urothelial carcinoma (UTUC), with individual chapters on diagnosis, nephron-sparing surgery, nephroureterectomy, and treatment of advanced or metastatic UTUC. The text is supported by many illustrations, photos, and tables that clarify management, and surgical video clips are also available to readers. The book will be a welcome addition to the literature as progress continues to be made in understanding the exact pathophysiology of urothelial carcinoma and in developing more effective diagnostic and therapeutic modalities. It will be useful both to researchers in the field of urothelial carcinoma and to clinicians, including especially residents and fellows.
No hay comentarios en este titulo.